Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri

Cancer

Volumn 115, Issue 16, 2009, Pages 3749-3757

  D'Urso, Oscar Fernando ^a,b   D'Urso, Pietro Ivo ^b   Marsigliante, Santo ^a   Storelli, Carlo ^a   Luzi, Giuseppe ^c   Gianfreda, Cosimo Damiano ^d   Montinaro, Antonio ^d   Distante, Alessandro ^e   Ciappetta, Pasqualino ^b  

^a Ecotekne ^*  (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d VITO FAZZI HOSPITAL   (Italy)

^e CNR   (Italy)

Author keywords

Gene expression patterns; Gliomatosis cerebri; Polymerase chain reaction; Prognosis; PTEN; TP53

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CORRELATION ANALYSIS; GENE; GENE EXPRESSION PROFILING; GLIOMA; GLIOMATOSIS CEREBRI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PTEN GENE; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TP53 GENE;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, NEUROEPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 68549119013     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24435     Document Type: Article

References (22)

1. Cummings TJ, Hulette CM, Longee DC, et al. Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol. 1999;18:190-197.
2. Mawrin C, Aumann V, Kirches E, et al. Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol. 2001;55:11-17.
3. Herrlinger U, Felsberg J, Kuker W, et al. Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol. 2002;52:390-399.
4. Izumiyama H, Abe T, Tanioka D. Gliomatosis cerebri in a young patient showing various cranial nerve manifestations: a case report. Brain Tumor Pathol. 2003;20:93-96.
5. Filley CM, Kleinschmidt-DeMasters BK, Lillehei KO, et al. Gliomatosis cerebri: neurobehavioral and neuropathological observations. Cogn Behav Neurol. 2003;16:149-159.
6. Fuller GN, Kros JM. Gliomatosis cerebri. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC; 2007:50-52.
7. Mawrin C, Kirches E, Schneider-Stock R, et al. Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol. 2003;105:529-536.
8. Sanson M, Cartalat-Carel S, Taillibert S, et al. Initial chemotherapy in gliomatosis cerebri. Neurology. 2004;63:270-275.
9. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology. 1999;1:44-51.
10. National Center for Biotechnology Information. Gene Expression Omnibus accession display. Available at: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? token=phidfoiuwugiife& acc=GSE11822 Accessed on. . .
11. MacQueen JB. Some methods for classification and analysis of multivariate observations. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Vol 1. Berkeley, CA: University of California Press; 1967:281-297.
12. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression. Science. 1999;286:531-537.
13. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Monterey, CA: Wadsworth and Brooks/Cole Advanced Books and Software; 1984.
14. Slonim DK, Tamayo P, Mesirov JP, Golub TR, Lander ES. Class prediction and discovery using gene expression data. In: Proceedings of the Fourth Annual International Conference on Computational Molecular Biology (RECOMB). New York, NY: ACM Press; 2000:263-272.
15. Cavenee WK. High-grade gliomas with chromosome 1p loss. J Neurosurg. 2000;92:1080-1081.
16. Mawrin C, Kirches E, Schneider-Stock R, et al. Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol. 2005;72:115-122.
17. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature. 1992;355:846-847.
18. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H. p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol. 1998;95:559-564.
19. Tohma Y, Gratas C, Biernat W, et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol. 1998;57:684-689.
20. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
21. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536-540.
22. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63:1602-1607.